SkinHealth Systems Inc. (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
16.31
+0.35 (2.19%)
Nov 13, 2026, 4:00 PM EST - Market closed
SkinHealth Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 288.56 | 300.79 | 334.29 | 397.99 | 365.88 | 260.09 | |
Revenue Growth | -4.42% | -10.02% | -16.00% | 8.78% | 40.67% | 118.39% |
Cost of Revenue | 94.6 | 104.43 | 144 | 242.88 | 117.1 | 81.55 |
Gross Profit | 193.96 | 196.36 | 190.3 | 155.11 | 248.78 | 178.54 |
Selling, General & Admin | 181.2 | 211.54 | 243.77 | 275.93 | 266.18 | 210.27 |
Research & Development | 5.85 | 5.63 | 6.3 | 10.1 | 8.44 | 8.2 |
Operating Expenses | 187.05 | 217.17 | 250.07 | 286.03 | 274.62 | 218.47 |
Operating Income | 6.91 | -20.8 | -59.77 | -130.92 | -25.84 | -39.93 |
Interest Expense | -25.29 | -19.33 | -10.41 | -13.65 | -13.39 | -11.78 |
Interest & Investment Income | 5.68 | 8.95 | 16.64 | 23.17 | 9.18 | 0.04 |
Currency Exchange Gain (Loss) | -1.86 | 5.82 | -4.64 | 2.39 | -1.3 | -0.07 |
Other Non Operating Income (Expenses) | -16.74 | 1.32 | 3.23 | 17.12 | 76.69 | -277.5 |
EBT Excluding Unusual Items | -31.29 | -24.04 | -54.95 | -101.89 | 45.34 | -329.24 |
Merger & Restructuring Charges | - | - | -8 | - | - | - |
Other Unusual Items | 18.1 | 18.1 | 33.4 | - | - | -51.4 |
Pretax Income | -13.19 | -5.94 | -29.55 | -101.89 | 45.34 | -380.64 |
Income Tax Expense | 5.1 | 3.58 | -0.45 | -1.77 | 1.12 | -1.88 |
Earnings From Continuing Operations | - | -9.52 | -29.1 | -100.12 | 44.22 | -378.76 |
Net Income | -18.29 | -9.52 | -29.1 | -100.12 | 44.22 | -378.76 |
Net Income to Common | -18.29 | -9.52 | -29.1 | -100.12 | 44.22 | -378.76 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 7 | 7 | 5 |
Shares Outstanding (Diluted) | 6 | 7 | 7 | 7 | 7 | 5 |
Shares Change | 2.50% | -4.70% | 8.21% | -11.33% | 45.43% | 197.77% |
EPS (Basic) | -2.84 | -1.51 | -4.70 | -15.21 | 5.99 | -74.18 |
EPS (Diluted) | -2.84 | -3.26 | -7.27 | -15.21 | -4.59 | -74.20 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 22.69 | 37.18 | 15.38 | -0.53 | -118.92 | -39.56 |
Free Cash Flow Per Share | 3.52 | 5.48 | 2.16 | -0.08 | -16.02 | -7.75 |
Gross Margin | 67.22% | 65.28% | 56.93% | 38.97% | 68.00% | 68.65% |
Operating Margin | 2.40% | -6.92% | -17.88% | -32.89% | -7.06% | -15.35% |
Profit Margin | -6.34% | -3.16% | -8.70% | -25.16% | 12.09% | -145.63% |
Free Cash Flow Margin | 7.86% | 12.36% | 4.60% | -0.13% | -32.50% | -15.21% |
EBITDA | 28.14 | 4.55 | -26.09 | -96.24 | -2.97 | -22 |
EBITDA Margin | 9.75% | 1.51% | -7.81% | -24.18% | -0.81% | -8.46% |
D&A For EBITDA | 21.23 | 25.35 | 33.68 | 34.68 | 22.87 | 17.93 |
EBIT | 6.91 | -20.8 | -59.77 | -130.92 | -25.84 | -39.93 |
EBIT Margin | 2.40% | -6.92% | -17.88% | -32.89% | -7.06% | -15.35% |
Effective Tax Rate | - | - | - | - | 2.46% | - |
Advertising Expenses | - | 6 | 8.7 | 9.9 | 3.8 | 3.2 |